170 related articles for article (PubMed ID: 19919522)
1. Fetal and maternal angiogenic/anti-angiogenic factors in normal and preeclamptic pregnancy.
Catarino C; Rebelo I; Belo L; Rocha S; Castro EB; PatrÃcio B; Quintanilha A; Santos-Silva A
Growth Factors; 2009 Dec; 27(6):345-51. PubMed ID: 19919522
[TBL] [Abstract][Full Text] [Related]
2. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate.
Romero R; Nien JK; Espinoza J; Todem D; Fu W; Chung H; Kusanovic JP; Gotsch F; Erez O; Mazaki-Tovi S; Gomez R; Edwin S; Chaiworapongsa T; Levine RJ; Karumanchi SA
J Matern Fetal Neonatal Med; 2008 Jan; 21(1):9-23. PubMed ID: 18175241
[TBL] [Abstract][Full Text] [Related]
3. The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age.
Erez O; Romero R; Espinoza J; Fu W; Todem D; Kusanovic JP; Gotsch F; Edwin S; Nien JK; Chaiworapongsa T; Mittal P; Mazaki-Tovi S; Than NG; Gomez R; Hassan SS
J Matern Fetal Neonatal Med; 2008 May; 21(5):279-87. PubMed ID: 18446652
[TBL] [Abstract][Full Text] [Related]
4. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia.
Ahmad S; Ahmed A
Circ Res; 2004 Oct; 95(9):884-91. PubMed ID: 15472115
[TBL] [Abstract][Full Text] [Related]
5. Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion.
Soto E; Romero R; Kusanovic JP; Ogge G; Hussein Y; Yeo L; Hassan SS; Kim CJ; Chaiworapongsa T
J Matern Fetal Neonatal Med; 2012 May; 25(5):498-507. PubMed ID: 21867402
[TBL] [Abstract][Full Text] [Related]
6. Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin.
Bujold E; Romero R; Chaiworapongsa T; Kim YM; Kim GJ; Kim MR; Espinoza J; Gonçalves LF; Edwin S; Mazor M
J Matern Fetal Neonatal Med; 2005 Jul; 18(1):9-16. PubMed ID: 16105786
[TBL] [Abstract][Full Text] [Related]
7. A longitudinal study of circulating angiogenic and antiangiogenic factors and AT1-AA levels in preeclampsia.
Sahay AS; Patil VV; Sundrani DP; Joshi AA; Wagh GN; Gupte SA; Joshi SR
Hypertens Res; 2014 Aug; 37(8):753-8. PubMed ID: 24718301
[TBL] [Abstract][Full Text] [Related]
8. Relationship between maternal and cord blood hemostatic disturbances in preeclamptic pregnancies.
Catarino C; Rebelo I; Belo L; Rocha S; Castro EB; Patricio B; Quintanilha A; Santos-Silva A
Thromb Res; 2008; 123(2):219-24. PubMed ID: 18384840
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers of endothelial dysfunction in preeclampsia and neonatal morbidity: a case-control study.
Masoura S; Kalogiannidis I; Makedou K; Theodoridis T; Koiou K; Gerou S; Athanasiadis A; Agorastos T
Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():119-23. PubMed ID: 24485669
[TBL] [Abstract][Full Text] [Related]
10. Maternal/newborn VEGF-C936T interaction and its influence on the risk, severity and prognosis of preeclampsia, as well as on the maternal angiogenic profile.
Procopciuc LM; Caracostea G; Zaharie G; Stamatian F
J Matern Fetal Neonatal Med; 2014 Nov; 27(17):1754-60. PubMed ID: 25007988
[TBL] [Abstract][Full Text] [Related]
11. Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction.
Wallner W; Sengenberger R; Strick R; Strissel PL; Meurer B; Beckmann MW; Schlembach D
Clin Sci (Lond); 2007 Jan; 112(1):51-7. PubMed ID: 16928195
[TBL] [Abstract][Full Text] [Related]
12. Acute pyelonephritis during pregnancy changes the balance of angiogenic and anti-angiogenic factors in maternal plasma.
Chaiworapongsa T; Romero R; Gotsch F; Kusanovic JP; Mittal P; Kim SK; Erez O; Vaisbuch E; Mazaki-Tovi S; Kim CJ; Dong Z; Yeo L; Hassan SS
J Matern Fetal Neonatal Med; 2010 Feb; 23(2):167-78. PubMed ID: 20213923
[TBL] [Abstract][Full Text] [Related]
13. The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation.
Chaiworapongsa T; Espinoza J; Gotsch F; Kim YM; Kim GJ; Goncalves LF; Edwin S; Kusanovic JP; Erez O; Than NG; Hassan SS; Romero R
J Matern Fetal Neonatal Med; 2008 Jan; 21(1):25-40. PubMed ID: 18175242
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast.
Munaut C; Lorquet S; Pequeux C; Blacher S; Berndt S; Frankenne F; Foidart JM
Hum Reprod; 2008 Jun; 23(6):1407-15. PubMed ID: 18413304
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences.
Tsatsaris V; Goffin F; Munaut C; Brichant JF; Pignon MR; Noel A; Schaaps JP; Cabrol D; Frankenne F; Foidart JM
J Clin Endocrinol Metab; 2003 Nov; 88(11):5555-63. PubMed ID: 14602804
[TBL] [Abstract][Full Text] [Related]
16. Maternal plasma soluble fms-like tyrosine kinase-1 and free vascular endothelial growth factor at 11 to 13 weeks of gestation in preeclampsia.
Akolekar R; de Cruz J; Foidart JM; Munaut C; Nicolaides KH
Prenat Diagn; 2010 Mar; 30(3):191-7. PubMed ID: 20101671
[TBL] [Abstract][Full Text] [Related]
17. An imbalance between angiogenic and anti-angiogenic factors precedes fetal death in a subset of patients: results of a longitudinal study.
Romero R; Chaiworapongsa T; Erez O; Tarca AL; Gervasi MT; Kusanovic JP; Mittal P; Ogge G; Vaisbuch E; Mazaki-Tovi S; Dong Z; Kim SK; Yeo L; Hassan SS
J Matern Fetal Neonatal Med; 2010 Dec; 23(12):1384-99. PubMed ID: 20459337
[TBL] [Abstract][Full Text] [Related]
18. Altered methylation and expression patterns of genes regulating placental angiogenesis in preterm pregnancy.
Sundrani DP; Reddy US; Chavan-Gautam PM; Mehendale SS; Chandak GR; Joshi SR
Reprod Sci; 2014 Dec; 21(12):1508-17. PubMed ID: 24803508
[TBL] [Abstract][Full Text] [Related]
19. Excess soluble fms-like tyrosine kinase 1 and low platelet counts in premature neonates of preeclamptic mothers.
Tsao PN; Wei SC; Su YN; Chou HC; Chen CY; Hsieh WS
Pediatrics; 2005 Aug; 116(2):468-72. PubMed ID: 16061605
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of circulating autoantibodies against VEGF-A, VEGFR-1 and PlGF in preeclampsia - A role in placental and vascular health?
Moe K; Heidecke H; Dechend R; Staff AC
Pregnancy Hypertens; 2017 Oct; 10():83-89. PubMed ID: 29153696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
